Cytokinetics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Cytokinetics Stock Summary

Cytokinetics competes with Edgewise Therapeutics, Dyne Therapeutics, Stoke Therapeutics, Pliant Therapeutics, and Revolution Medicines. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company was incorporated in 1997 and is headquartered in South San Francisco, California. Cytokinetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 253 people.

Cytokinetics Key Financial Ratios

Cytokinetics Key Balance Sheet Accounts

Cytokinetics Key Income Statement Accounts

Cytokinetics Key Cash Accounts

Cytokinetics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cytokinetics's current stock value. Our valuation model uses many indicators to compare Cytokinetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytokinetics competition to find correlations between indicators driving Cytokinetics's intrinsic value. More Info.Cytokinetics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Cytokinetics' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cytokinetics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Cytokinetics Systematic Risk

Today, most investors in Cytokinetics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cytokinetics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cytokinetics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Cytokinetics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cytokinetics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cytokinetics based on widely used predictive technical indicators. In general, we focus on analyzing Cytokinetics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cytokinetics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytokinetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.